{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T17:59:18Z","timestamp":1703181558048},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,2,20]],"date-time":"2014-02-20T00:00:00Z","timestamp":1392854400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2458-14-183","type":"journal-article","created":{"date-parts":[[2014,2,20]],"date-time":"2014-02-20T10:03:58Z","timestamp":1392890638000},"source":"Crossref","is-referenced-by-count":13,"title":["Timing of antiretroviral therapy and regimen for HIV-infected patients with tuberculosis: the effect of revised HIV guidelines in Malawi"],"prefix":"10.1186","volume":"14","author":[{"given":"Hannock","family":"Tweya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Ben-Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mike","family":"Kalulu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Jahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wingston","family":"Ng\u2019ambi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Mkandawire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Layout","family":"Gabriel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sam","family":"Phiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,2,20]]},"reference":[{"key":"6391_CR1","volume-title":"Global tuberculosis control report 2011","author":"World Health Organisation","year":"2011","unstructured":"World Health Organisation: Global tuberculosis control report 2011. 2011, Geneva: World Health Organisation, WHO\/HTM\/TB\/2011.16"},{"issue":"2","key":"6391_CR2","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1097\/00002030-200101260-00002","volume":"15","author":"YD Mukadi","year":"2001","unstructured":"Mukadi YD, Maher D, Harries A: Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa. AIDS (London, Engl). 2001, 15 (2): 143-152. 10.1097\/00002030-200101260-00002.","journal-title":"AIDS (London, Engl)"},{"issue":"5","key":"6391_CR3","doi-asserted-by":"publisher","first-page":"e5575","DOI":"10.1371\/journal.pone.0005575","volume":"4","author":"A Zolopa","year":"2009","unstructured":"Zolopa A, Andersen J, Powderly W, Sanchez A, Sanne I, Suckow C, Hogg E, Komarow L: Early antiretroviral therapy reduces AIDS progression\/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial. PloS One. 2009, 4 (5): e5575-10.1371\/journal.pone.0005575.","journal-title":"PloS One"},{"issue":"9","key":"6391_CR4","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1086\/424676","volume":"190","author":"K Dheda","year":"2004","unstructured":"Dheda K, Lampe FC, Johnson MA, Lipman MC: Outcome of HIV-associated tuberculosis in the era of highly active antiretroviral therapy. J Infect Dis. 2004, 190 (9): 1670-1676. 10.1086\/424676.","journal-title":"J Infect Dis"},{"issue":"8","key":"6391_CR5","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1056\/NEJMoa0905848","volume":"362","author":"SS Abdool Karim","year":"2010","unstructured":"Abdool Karim SS, Naidoo K, Grobler A, Padayatchi N, Baxter C, Gray A, Gengiah T, Nair G, Bamber S, Singh A, et al: Timing of initiation of antiretroviral drugs during tuberculosis therapy. N Engl J Med. 2010, 362 (8): 697-706. 10.1056\/NEJMoa0905848.","journal-title":"N Engl J Med"},{"issue":"16","key":"6391_CR6","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1056\/NEJMoa1013607","volume":"365","author":"DV Havlir","year":"2011","unstructured":"Havlir DV, Kendall MA, Ive P, Kumwenda J, Swindells S, Qasba SS, Luetkemeyer AF, Hogg E, Rooney JF, Wu X, et al: Timing of antiretroviral therapy for HIV-1 infection and tuberculosis. N Engl J Med. 2011, 365 (16): 1482-1491. 10.1056\/NEJMoa1013607.","journal-title":"N Engl J Med"},{"issue":"16","key":"6391_CR7","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1056\/NEJMoa1013911","volume":"365","author":"FX Blanc","year":"2011","unstructured":"Blanc FX, Sok T, Laureillard D, Borand L, Rekacewicz C, Nerrienet E, Madec Y, Marcy O, Chan S, Prak N, et al: Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis. N Engl J Med. 2011, 365 (16): 1471-1481. 10.1056\/NEJMoa1013911.","journal-title":"N Engl J Med"},{"key":"6391_CR8","volume-title":"Antiretroviral drugs for treating pregnant women and preventing HIV infections in infants: recommendations for public approach - 2010 revision","author":"World Health Organisation","year":"2010","unstructured":"World Health Organisation: Antiretroviral drugs for treating pregnant women and preventing HIV infections in infants: recommendations for public approach - 2010 revision. 2010, Geneva: World Health Organisation, http:\/\/whqlibdoc.who.int\/publications\/2010\/9789241599818_eng.pdf?ua=1 ,"},{"key":"6391_CR9","volume-title":"Global tuberculosis control report 2013","author":"World Health Organisation","year":"2013","unstructured":"World Health Organisation: Global tuberculosis control report 2013. 2013, Geneva: World Health Organisation, WHO\/HTM\/TB\/2013.15"},{"key":"6391_CR10","volume-title":"Integrated HIV program report: July - September 2012","author":"Malawi Ministry of Health","year":"2012","unstructured":"Malawi Ministry of Health: Integrated HIV program report: July - September 2012. 2012, Lilongwe Ministry of Health, HIV Department, http:\/\/www.hivunitmohmw.org\/uploads\/Main\/Quarterly_HIV_Programme_Report_2012_Q3.pdf ,"},{"issue":"13","key":"6391_CR11","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1097\/QAD.0b013e32832d3b6d","volume":"23","author":"SD Lawn","year":"2009","unstructured":"Lawn SD, Myer L, Edwards D, Bekker LG, Wood R: Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa. AIDS (London, Engl). 2009, 23 (13): 1717-1725. 10.1097\/QAD.0b013e32832d3b6d.","journal-title":"AIDS (London, Engl)"},{"issue":"4","key":"6391_CR12","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.ccm.2009.08.010","volume":"30","author":"SD Lawn","year":"2009","unstructured":"Lawn SD, Kranzer K, Wood R: Antiretroviral therapy for control of the HIV-associated tuberculosis epidemic in resource-limited settings. Clin Chest Med. 2009, 30 (4): 685-699. 10.1016\/j.ccm.2009.08.010. viii","journal-title":"Clin Chest Med"},{"key":"6391_CR13","unstructured":"Tuberculosis country profiles. https:\/\/extranet.who.int\/sree\/Reports?op=Replet&name=%2FWHO_HQ_Reports%2FG2%2FPROD%2FEXT%2FTBCountryProfile&ISO2=MW&outtype=html ,"},{"key":"6391_CR14","unstructured":"Clinical management of HIV in children and adults; integrated guidelines for providing HIV services. http:\/\/www.hivunitmohmw.org\/uploads\/Main\/Malawi%20Integrated%20Guidelines%20for%20Clinical%20Management%20of%20HIV%202011%20First%20Edition.pdf ,"},{"issue":"11","key":"6391_CR15","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1111\/j.1365-3156.2011.02848.x","volume":"16","author":"S Phiri","year":"2011","unstructured":"Phiri S, Khan PY, Grant AD, Gareta D, Tweya H, Kalulu M, Chaweza T, Mbetewa L, Kanyerere H, Weigel R, et al: Integrated tuberculosis and HIV care in a resource-limited setting: experience from the Martin Preuss centre, Malawi. Trop Med Int Health. 2011, 16 (11): 1397-1403. 10.1111\/j.1365-3156.2011.02848.x.","journal-title":"Trop Med Int Health"},{"issue":"12","key":"6391_CR16","doi-asserted-by":"crossref","first-page":"936","DOI":"10.7196\/SAMJ.6024","volume":"102","author":"MD Nglazi","year":"2012","unstructured":"Nglazi MD, Kaplan R, Caldwell J, Peton N, Lawn SD, Wood R, Bekker LG: Antiretroviral treatment uptake in patients with HIV-associated TB attending co-located TB and ART services. South Af Med J Suid. 2012, 102 (12): 936-939.","journal-title":"South Af Med J Suid"},{"issue":"5","key":"6391_CR17","doi-asserted-by":"publisher","first-page":"e19484","DOI":"10.1371\/journal.pone.0019484","volume":"6","author":"DJ Pepper","year":"2011","unstructured":"Pepper DJ, Marais S, Wilkinson RJ, Bhaijee F, De Azevedo V, Meintjes G: Barriers to initiation of antiretrovirals during antituberculosis therapy in Africa. PloS One. 2011, 6 (5): e19484-10.1371\/journal.pone.0019484.","journal-title":"PloS One"},{"issue":"8","key":"6391_CR18","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1177\/135965350501000809","volume":"10","author":"RS Autar","year":"2005","unstructured":"Autar RS, Wit FW, Sankote J, Mahanontharit A, Anekthananon T, Mootsikapun P, Sujaikaew K, Cooper DA, Lange JM, Phanuphak P, et al: Nevirapine plasma concentrations and concomitant use of rifampin in patients coinfected with HIV-1 and tuberculosis. Antiviral Ther. 2005, 10 (8): 937-943.","journal-title":"Antiviral Ther"},{"issue":"5","key":"6391_CR19","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1001\/jama.300.5.530","volume":"300","author":"A Boulle","year":"2008","unstructured":"Boulle A, Van Cutsem G, Cohen K, Hilderbrand K, Mathee S, Abrahams M, Goemaere E, Coetzee D, Maartens G: Outcomes of nevirapine- and efavirenz-based antiretroviral therapy when coadministered with rifampicin-based antitubercular therapy. Jama. 2008, 300 (5): 530-539. 10.1001\/jama.300.5.530.","journal-title":"Jama"},{"issue":"4","key":"6391_CR20","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1177\/135965350701200406","volume":"12","author":"JJ van Oosterhout","year":"2007","unstructured":"van Oosterhout JJ, Kumwenda JJ, Beadsworth M, Mateyu G, Longwe T, Burger DM, Zijlstra EE: Nevirapine-based antiretroviral therapy started early in the course of tuberculosis treatment in adult Malawians. Antiviral Ther. 2007, 12 (4): 515-521.","journal-title":"Antiviral Ther"},{"issue":"5","key":"6391_CR21","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1097\/00002030-200003310-00017","volume":"14","author":"RA Breen","year":"2000","unstructured":"Breen RA, Lipman MC, Johnson MA: Increased incidence of peripheral neuropathy with co-administration of stavudine and isoniazid in HIV-infected individuals. AIDS (London, Engl). 2000, 14 (5): 615-10.1097\/00002030-200003310-00017.","journal-title":"AIDS (London, Engl)"},{"issue":"1","key":"6391_CR22","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1310\/R8M7-EQ0M-CNPW-39FC","volume":"2","author":"S Duran","year":"2001","unstructured":"Duran S, Spire B, Raffi F, Walter V, Bouhour D, Journot V, Cailleton V, Leport C, Moatti JP: Self-reported symptoms after initiation of a protease inhibitor in HIV-infected patients and their impact on adherence to HAART. HIV Clin Trials. 2001, 2 (1): 38-45. 10.1310\/R8M7-EQ0M-CNPW-39FC.","journal-title":"HIV Clin Trials"},{"issue":"5","key":"6391_CR23","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1097\/00042560-200112150-00006","volume":"28","author":"A Ammassari","year":"2001","unstructured":"Ammassari A, Murri R, Pezzotti P, Trotta MP, Ravasio L, De Longis P, Lo Caputo S, Narciso P, Pauluzzi S, Carosi G, et al: Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection. J Acquir Immun Def Syndro (1999). 2001, 28 (5): 445-449. 10.1097\/00042560-200112150-00006.","journal-title":"J Acquir Immun Def Syndro (1999)"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-14-183.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2458-14-183\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-14-183","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T16:15:28Z","timestamp":1689005728000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/1471-2458-14-183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,20]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["6391"],"URL":"https:\/\/doi.org\/10.1186\/1471-2458-14-183","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,20]]},"article-number":"183"}}